Skip to main navigation Skip to search Skip to main content

Pathophysiological roles of proteases in gastrointestinal disease

  • Laura E. Edgington-Mitchell

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

Gastrointestinal diseases, such as irritable bowel syndrome, inflammatory bowel disease, and colorectal cancer, affect a large proportion of the population and are associated with many unpleasant symptoms. Although the causes of these diseases remain largely unknown, there is increasing evidence to suggest that dysregulated protease activity may be a contributing factor. Proteases are enzymes that cleave other proteins, and their activity is normally very tightly regulated. During disease, however, the balance between proteases and their inhibitors is often shifted, leading to altered spatial and temporal control of substrate cleavage. Evaluating protease levels in normal physiology and disease has relied heavily on the use of chemical tools. Although these tools have greatly advanced the field, they are not without caveats. This review provides an introduction to these tools, their application in the gut, and a summary of the current knowledge on the contribution of protease activity to gastrointestinal disease.

Original languageEnglish
Pages (from-to)G234-G239
Number of pages6
Journal American Journal of Physiology - Gastrointestinal and Liver Physiology
Volume310
Issue number4
DOIs
Publication statusPublished - 15 Feb 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Activity-based probes
  • Colorectal cancer
  • Inflammatory bowel disease
  • Irritable bowel disease
  • Protease

Cite this